Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  82 results for ""COVID-19 Vaccines""

Your Filters

Publication : ebiomedicine Subject : covid-19 Subject : emotional engagement Subject : spike glycoprotein, coronavirus Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

IL-1 receptor 1 signaling shapes the development of viral antigen-specific CD4 + T cell responses following COVID-19 mRNA vaccination.

  • Authors : Park HJ; Department of Internal Medicine (Section of Rheumatology, Allergy & Immunology), Yale University School of Medicine, New Haven, CT, 06520, USA.; Shin MS

Subjects: CD4-Positive T-Lymphocytes*/CD4-Positive T-Lymphocytes*/CD4-Positive T-Lymphocytes*/immunology ; CD4-Positive T-Lymphocytes*/CD4-Positive T-Lymphocytes*/CD4-Positive T-Lymphocytes*/metabolism ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology

  • Source: EBioMedicine [EBioMedicine] 2024 May; Vol. 103, pp. 105114. Date of Electronic Publication: 2024 Apr 18.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis.

  • Authors : Martin P; Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London W12 0HS, United Kingdom. Electronic address: .; Clarke C

Subjects: Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*immunology ; COVID-19/COVID-19/COVID-19/*prevention & control ; COVID-19 Vaccines/COVID-19 Vaccines/COVID-19 Vaccines/*therapeutic use

  • Source: EBioMedicine [EBioMedicine] 2021 Sep; Vol. 71, pp. 103567. Date of Electronic Publication: 2021 Aug 26.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Lack of evidence of significant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens.

  • Authors : Marrama D; La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.; Mahita J

Subjects: Antigens/Antigens/Antigens/*genetics ; COVID-19/COVID-19/COVID-19/*genetics ; Epitopes/Epitopes/Epitopes/*genetics

  • Source: EBioMedicine [EBioMedicine] 2022 Jan; Vol. 75, pp. 103807. Date of Electronic Publication: 2022 Jan 06.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate.

  • Authors : Sun W; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.; Leist SR

Subjects: COVID-19*/COVID-19*/COVID-19*/genetics ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: EBioMedicine [EBioMedicine] 2020 Dec; Vol. 62, pp. 103132. Date of Electronic Publication: 2020 Nov 21.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses.

  • Authors : Pattinson D; Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53706, USA.; Jester P

Subjects: Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/immunology ; Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/administration & dosage ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood

  • Source: EBioMedicine [EBioMedicine] 2024 May; Vol. 103, pp. 105103. Date of Electronic Publication: 2024 Apr 03.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines-an exploratory sub-study of the BRACE trial.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: EBioMedicine [EBioMedicine] 2024 May; Vol. 103, pp. 105100. Date of Electronic Publication: 2024 Apr 24.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine.

  • Authors : Odak I; Institute of Immunology, Hannover Medical School, Germany.; Riemann L

Subjects: COVID-19 Vaccines* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

  • Source: EBioMedicine [EBioMedicine] 2024 Jan; Vol. 99, pp. 104947. Date of Electronic Publication: 2023 Dec 30.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Mucosal SARS-CoV-2 vaccination of rodents elicits superior systemic T central memory function and cross-neutralising antibodies against variants of concern.

  • Authors : O'Neill A; Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 169857, Singapore.; Mantri CK

Subjects: COVID-19 Vaccines* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Cricetinae

  • Source: EBioMedicine [EBioMedicine] 2024 Jan; Vol. 99, pp. 104924. Date of Electronic Publication: 2023 Dec 18.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster.

  • Authors : Nolan TM; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection & Immunity, Melbourne, Australia; Murdoch Children's Research Institute, Melbourne, Australia. Electronic address: .

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects; Adult SARS-CoV-2 variants

  • Source: EBioMedicine [EBioMedicine] 2023 Dec; Vol. 98, pp. 104878. Date of Electronic Publication: 2023 Nov 27.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Risk of COVID-19 after natural infection or vaccination.

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*

  • Source: EBioMedicine [EBioMedicine] 2023 Oct; Vol. 96, pp. 104799. Date of Electronic Publication: 2023 Sep 20.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  82 results for ""COVID-19 Vaccines""